Full name
"AMFAR" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | -11,4 | 0 | -8,1 | ∞ |
EBITDA | -11,4 | 0 | -8,1 | ∞ |
Income tax | ||||
Equity capital | 23 | 23 | 14,9 | -35,2 |
Operating profit (EBIT) | -11,4 | 0 | -8,1 | ∞ |
Assets | 0 | 23 | 14,9 | -35,2 |
Net profit (loss) | -11,4 | 0 | -8,1 | ∞ |
Net income from sale | 0 | 0 | 0 | 0 |
Liabilities and provisions for liabilities | 0 | 0 | 0 | 0 |
Working assets | 23 | 23 | 14,9 | -35,2 |
Depreciation | 0 | 0 | 0 | 0 |
Basic operational activity income | ||||
% | % | % | p.p. | |
Profitability of capital | ||||
Equity capital to total assets | 100 | 100 | 0 | |
Gross profit margin | -16,6 | |||
EBITDA Margin | -1,8 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane